nephropathy

(redirected from nephropathic)
Also found in: Dictionary, Medical, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for nephropathy

References in periodicals archive ?
Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS).
Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops.
Biopharmaceutical company Raptor Pharmaceutical Corp (NasdaqGM:RPTP) reported on Thursday the receipt of marketing approval from the European Commission (EC) for PROCYSBI for the treatment of proven nephropathic cystinosis EC in the European Union (EU).
Nephropathic cystinosis, an orphan disease, is estimated to effect a population of 2,000 patients worldwide, including 500 patients in the U.
Kaiser-Kupfer experienced success in reducing visual loss associated with the rare metabolic disorders gyrate atrophy and nephropathic cystinosis.
Long-term treatment with growth hormone in short children with nephropathic cystinosis.
Benefits of Intensive Insulin Therapy Formerly on Formerly on Nephropathic Intensive Therapy Conventional Therapy Outcome (n = 687) (n = 688) Hypertension 29.
Benefits of Intesive Insulin Therapy Formerly on Formerly on Nephropathic Intensive Therapy Conventional Therapy Outcome (n = 687) (n = 688) Hypertension 29.
There are three types of cystinosis, which can appear at any age: infantile nephropathic (usually from 6-8 months after birth), late-onset nephropathic (usually between ages 12 and 13), and benign non-nephropathic (usually in adulthood).
com/research/sgngb4/raptors_rp_103) has announced the addition of the "Raptor's RP 103 for nephropathic cystinosis - an orphan genetic disease" report to their offering.
Chronic Kidney Disease Stage 1 to 3) and to compare the mean magnesium levels in diabetic nephropathic patients and non-diabetic nephropathic patients.
2,3) Cystinosis can clinically manifest as a nephropathic or non-nephropathic form.
The acquisition sees the addition of Procysbi, a treatment for nephropathic cystinosis, a rare metabolic disorder, and Quinsair, which is given to cystic fibrosis patients, to Horizons rare disease portfolio.
Mitochondrial autophagy promotes cellular injury in nephropathic cystinosis," Journal of the American Society of Nephrology, vol.